In addition, due to the dual but contrasting effects of autophagy modulation in cancer [104], STAU1-mediated autophagy control may differentially impact cancer progression under various circumstances (i.e., tumor type, disease stage, treatment regimen, mutational status of tumor suppressors and oncogenes, etc.). Here, STAU1 is linked to neoplasm.